HAEMSTAR: HAEMATOLOGY SPECIALTY TRAINING AUDIT AND RESEARCH
We promote clinical research in Classical Haematology. We do this by: increasing participants recruitment to classical haematology clinical trials; transitioning local audits to large, national ones; developing our own studies; increasing exposure of haematology registrars to the NHS research environment.
Financial health, per its FY2025 accounts
The accounts state that unrestricted reserves increased from £70,338 to £141,352 during the reporting period, with total income of £92,401 and spending of £47,130. The trustees report that there are no uncertainties about the charity continuing as a going concern and that all currently active projects are fully funded.
What the accounts disclose
Trustees
- Dr Phillip Lindsay Ross Nicolsonchair
- Dr Andrew James Doyle
- Dr Emily Antonia Millen
- Dr Richard John Buka
- Dr Tom Paul Bull
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/05/2025 | £92k | £47k |
| 31/05/2024 | £55k | £40k |
| 31/05/2023 | £53k | £5k |
Common questions
Is HAEMSTAR: HAEMATOLOGY SPECIALTY TRAINING AUDIT AND RESEARCH financially healthy?
Per its FY2025 accounts: The accounts state that unrestricted reserves increased from £70,338 to £141,352 during the reporting period, with total income of £92,401 and spending of £47,130. The trustees report that there are no uncertainties about the charity continuing as a going concern and that all currently active projects are fully funded. Its FY2025 accounts were independently examined.